$TGTX News Article - TG Therapeutics Announces Positive Topline Results from the ULTIMATE I & II Phase 3 Studies Evaluating Ublituximab Monotherapy for the Treatment of Patients with Multiple Sclerosis
https://marketwirenews.com/news-releases/tg-t...92334.html